CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers

China BlueChem Reports Revenue of RMB5.850 Billion and Profit of RMB641 Million for 2025 Interim

Australian Breakthrough by Cholrem: Cyclodextrin Therapy Reverses Heart Disease, Hailed as Greatest Advance Since Statins

Focus Graphite Announces Board Changes and Upcoming International Trade Mission with Natural Resources Canada

Shuangdeng Group Proposed Listing on the Main Board of the Hong Kong Stock Exchange

The 35th Food Expo and concurrent fairs attract over 500,000 visits

CENTRESTAGE 10th anniversary set to dazzle in September

Shoucheng Portfolio Wins 37 Medals at Humanoid Robot Games

Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC

OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively

RAK ICC Strengthens Foundations Regime with 2025 Legislative Enhancements

MMG Announces 2025 Interim Results, Profit, Earnings and Cash up on Strong Copper Growth

Formerra Becomes North American Distributor for Syensqo PVDF

How Do AI Workflow Automations Work?

Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million

The 35th Food Expo opens today

AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance

Re-opening of Food Expo and concurrent fairs